Gelonghui, January 21丨Lexin Healthcare (300562.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 32 million yuan to 36 million yuan, which is expected to turn a loss into a profit; net profit after deducting non-recurring profit and loss of 20 million yuan to 24 million yuan.
During the reporting period, the company was committed to improving the overall management level and quality of operations. By improving the budget control system, the management continued to strengthen cost reduction and efficiency measures to enhance the core competitiveness of products, and achieved significant improvements in unit labor efficiency output; total supply chain costs, direct labor and manufacturing costs were significantly improved. Actively adjust sales strategies externally and further optimize the customer structure. Through a series of reforms and continuous improvement measures, comprehensive gross margin increased significantly over the reporting period compared to the previous year.